Results 141 to 150 of about 12,381 (205)

Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas. [PDF]

Mol Cancer Ther
Orozco JJ, Matesan MC, Lundberg SJ, Haaf RL, Miyaoka RS, Fisher DR, Gooley TA, Green DJ, Sandmaier BM, Martin PS, Gopal AK.   +10 more
europepmc   +1 more source

From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review). [PDF]

Int J Oncol
Wang T, Zhou X, Yin X, Zhang A, Fan Y, Chen K, Tao H, Tang Z, Zhang P, He X, Yin L.   +10 more
europepmc   +1 more source

Mucins in ovarian cancer diagnosis and therapy [PDF]

, 2009
Subhash C Chauhan, Deepak Kumar, Meena Jaggi   +2 more
core   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

¹⁶¹Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas. [PDF]

J Nucl Med
Rioja-Blanco E, Banz Y, Schlapbach C, Novak U, Chiorazzo T, Bertschi NL, Bernhardt P, Grundler PV, van der Meulen NP, Grzmil M, Schibli R, Behe M.   +11 more
europepmc   +1 more source

An immunostimulant nanomedicine enhances radioimmunotherapy by remodeling the tumor immunosuppressive landscape after radiotherapy. [PDF]

Acta Pharm Sin B
Jiang M, Chen M, Zou W, Xie Y, Shi J, Liu J, Chen A, Zhao X.   +7 more
europepmc   +1 more source

Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma. [PDF]

BMC Cancer
Yin Z, Zhang H, Zhang K, Yue J, Tang R, Wang Y, Deng Q, Yu Q.   +7 more
europepmc   +1 more source

Evaluation of RC48-ADC in Combination with PRaG Regimen: An Open-Label, Prospective, Multicentre Study Assessing Efficacy and Safety for Advanced Refractory HER2-Expressing Solid Tumors (PRaG3.0 Study Protocol). [PDF]

Technol Cancer Res Treat
Xu M, Kong Y, Zhang J, Chen R, Xing P, Zhao X, Li S, Xu Y, Zhang L, Zou L.   +9 more
europepmc   +1 more source

Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with ²¹²Pb alpha-radioimmunotherapy targeting CD20. [PDF]

EJNMMI Res
Quelven I, Saidi A, Sage M, Mora-Ramirez E, Torgue J, Cogne M, Durand-Panteix S.   +6 more
europepmc   +1 more source

Treatment planning for molecular radiotherapy: potential and prospects [PDF]

, 2017
Aldridge, Matt, Bacher, Klaus, Brans, Boudewijn, Chiesa, Carlo, Cicone, Francesco, Gabina, Pablo Minguez, Gleisner, Katarina Sjogreen, Kobe, Carsten, Konijnenberg, Mark, Paphiti, Maria, Sandstrom, Mattias, Solny, Pavel, Spezi, Emiliano, Tipping, Jill, Wissmeyer, Michael   +14 more
core